These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9337199)

  • 1. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE.
    Bierhaus A; Illmer T; Kasper M; Luther T; Quehenberger P; Tritschler H; Wahl P; Ziegler R; Müller M; Nawroth PP
    Circulation; 1997 Oct; 96(7):2262-71. PubMed ID: 9337199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells.
    Bierhaus A; Chevion S; Chevion M; Hofmann M; Quehenberger P; Illmer T; Luther T; Berentshtein E; Tritschler H; Müller M; Wahl P; Ziegler R; Nawroth PP
    Diabetes; 1997 Sep; 46(9):1481-90. PubMed ID: 9287050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor.
    An XF; Zhou L; Jiang PJ; Yan M; Huang YJ; Zhang SN; Niu YF; Ten SC; Yu JY
    Mol Cell Biochem; 2011 Aug; 354(1-2):47-55. PubMed ID: 21461610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.
    Bierhaus A; Schiekofer S; Schwaninger M; Andrassy M; Humpert PM; Chen J; Hong M; Luther T; Henle T; Klöting I; Morcos M; Hofmann M; Tritschler H; Weigle B; Kasper M; Smith M; Perry G; Schmidt AM; Stern DM; Häring HU; Schleicher E; Nawroth PP
    Diabetes; 2001 Dec; 50(12):2792-808. PubMed ID: 11723063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells.
    Tanaka N; Yonekura H; Yamagishi S; Fujimori H; Yamamoto Y; Yamamoto H
    J Biol Chem; 2000 Aug; 275(33):25781-90. PubMed ID: 10829018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin-producing ability of endothelial cells through interactions with their receptors.
    Yamagishi S; Yamamoto Y; Harada S; Hsu CC; Yamamoto H
    FEBS Lett; 1996 Apr; 384(1):103-6. PubMed ID: 8797813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway.
    Guo ZJ; Niu HX; Hou FF; Zhang L; Fu N; Nagai R; Lu X; Chen BH; Shan YX; Tian JW; Nagaraj RH; Xie D; Zhang X
    Antioxid Redox Signal; 2008 Oct; 10(10):1699-712. PubMed ID: 18576917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways.
    Adamopoulos C; Piperi C; Gargalionis AN; Dalagiorgou G; Spilioti E; Korkolopoulou P; Diamanti-Kandarakis E; Papavassiliou AG
    Cell Mol Life Sci; 2016 Apr; 73(8):1685-98. PubMed ID: 26646068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
    Schmidt AM; Hori O; Chen JX; Li JF; Crandall J; Zhang J; Cao R; Yan SD; Brett J; Stern D
    J Clin Invest; 1995 Sep; 96(3):1395-403. PubMed ID: 7544803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of tubular epithelial cells in diabetic nephropathy.
    Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
    Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products.
    Marx N; Walcher D; Ivanova N; Rautzenberg K; Jung A; Friedl R; Hombach V; de Caterina R; Basta G; Wautier MP; Wautiers JL
    Diabetes; 2004 Oct; 53(10):2662-8. PubMed ID: 15448098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.
    Valencia JV; Mone M; Koehne C; Rediske J; Hughes TE
    Diabetologia; 2004 May; 47(5):844-52. PubMed ID: 15127201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
    Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
    Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE: a novel cellular receptor for advanced glycation end products.
    Schmidt AM; Hori O; Cao R; Yan SD; Brett J; Wautier JL; Ogawa S; Kuwabara K; Matsumoto M; Stern D
    Diabetes; 1996 Jul; 45 Suppl 3():S77-80. PubMed ID: 8674899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
    Kuniyasu H; Chihara Y; Kondo H
    Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.
    Yan SD; Schmidt AM; Anderson GM; Zhang J; Brett J; Zou YS; Pinsky D; Stern D
    J Biol Chem; 1994 Apr; 269(13):9889-97. PubMed ID: 8144582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shixiang Plaster, a Traditional Chinese Medicine, Promotes Healing in a Rat Model of Diabetic Ulcer Through the receptor for Advanced Glycation End Products (RAGE)/Nuclear Factor kappa B (NF-κB) and Vascular Endothelial Growth Factor (VEGF)/Vascular Cell Adhesion Molecule-1 (VCAM-1)/Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathways.
    Fei J; Ling YM; Zeng MJ; Zhang KW
    Med Sci Monit; 2019 Dec; 25():9446-9457. PubMed ID: 31825949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells.
    Kaji Y; Amano S; Usui T; Oshika T; Yamashiro K; Ishida S; Suzuki K; Tanaka S; Adamis AP; Nagai R; Horiuchi S
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):521-8. PubMed ID: 12556378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells.
    Higashi T; Sano H; Saishoji T; Ikeda K; Jinnouchi Y; Kanzaki T; Morisaki N; Rauvala H; Shichiri M; Horiuchi S
    Diabetes; 1997 Mar; 46(3):463-72. PubMed ID: 9032104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.